Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

SPB Exchange reports 2024 by IFRS

4/28/25 SPBE

Segezha Group reports for 2024 by IFRS

4/28/25 SGZH

Lenta reported for the 3 months of 2025

4/28/25 LENT

Lenta's retail revenue in Q1 up 23%

4/28/25 LENT

MGKL reported for 2024 by IFRS

4/28/25 MGKL

MD Medical's revenues in Q1 grew by 17%

4/28/25 MDMG

Sberbank reports for 3 months of 2025 by IFRS

4/28/25 SBER

International Trade Center reported for 3 months of 2025 according to RAS

4/26/25 WTCM

Board of Directors of Rosneft Oil Company recommended that dividends be paid for 2024

4/25/25 ROSN

Positive Technologies reported for 3 months of 2025 by RAS

4/25/25 POSI